#USA #Machine Learning #Costa Mesa #Amen Clinics #SPECT imaging

Innovative Research Reveals New Diagnostic Method for Schizophrenia

A transformative study published in NeuroImage Reports showcases the effectiveness of whole-brain Single Photon Emission Computed Tomography (SPECT) imaging, harnessed alongside advanced machine learning techniques, in successfully distinguishing individuals afflicted by schizophrenia from healthy counterparts. This significant development offers hope for more accurate psychiatric diagnosis and targeted treatment strategies.

The investigation, spearheaded by the researchers at the Tri-Institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS) in collaboration with Amen Clinics, meticulously analyzed SPECT scans from a sample group comprising 213 individuals. This group included 137 patients diagnosed with schizophrenia and 76 individuals without the disorder. By implementing a highly refined brain-network analysis known as spatially constrained Independent Component Analysis (sc-ICA), guided by the NeuroMark functional brain network template, the team was able to uncover distinct patterns of modified brain functions that correlate with schizophrenia.

Utilizing various machine learning algorithms for evaluation, researchers were surprised to discover that traditional Support Vector Machine (SVM) models—commonly used in functional MRI studies—were eclipsed by the performance of logistic regression and random forest classifiers. Specifically, logistic regression exhibited an impressive 87% sensitivity with 68% specificity, while the random forest algorithm achieved an 88% sensitivity along with a 61% specificity in differentiating between schizophrenia patients and healthy subjects.

Notably, the analysis pinpointed abnormalities within visual processing and cognitive control networks as predictive features of the disorder. Crucial brain regions identified as significant factors included the middle occipital gyrus, subthalamus, and putamen. This underscores the notion that schizophrenia involves complex disruptions in multiple interconnected brain networks, rather than localized anomalies.

Co-author Dr. Daniel Amen, founder and CEO of Amen Clinics, highlighted, "This work illustrates that brain SPECT imaging encompasses valuable network-level information. We can leverage this to deepen our understanding of schizophrenia." He emphasized that the findings bolster the notion of psychiatric disorders being intrinsically tied to brain function, dramatically shifting the landscape toward an objective approach utilizing functional neuroimaging.

The study's authors are optimistic about the potential implications of these findings, which could pave the way for more personalized assessments of risk, monitoring treatment efficacy, and pinpointing brain circuits associated with core symptoms, which include hallucinations, delusions, and cognitive deficits. They intend to conduct further studies with more extensive and balanced populations to validate these results and investigate multimodal imaging methodologies.

About Amen Clinics

Amen Clinics operates a nationwide network of brain health centers established by Daniel G. Amen, MD, a board-certified psychiatrist, physician, investigator, and best-selling author. For over three decades, the clinic has pioneered an innovative approach to brain health, assisting patients in comprehending the intricate link between brain functioning and various emotional, behavioral, cognitive, and mental health challenges. With a prestigious data repository consisting of the world's largest volume of brain SPECT scans pertinent to behavior, Amen Clinics aims to shift the narrative surrounding mental health from illness to proactive brain health.